<DOC>
	<DOCNO>NCT01238055</DOCNO>
	<brief_summary>The purpose study determine whether Sunitinib Docetaxel effective treatment advance gastric cancer patient prior chemotherapy fluoropyrimidine platinum .</brief_summary>
	<brief_title>Sunitinib + Docetaxel Second-line Treatment Gastric Cancer</brief_title>
	<detailed_description>This randomized phase II trial Sunitinib Docetaxel advance gastric cancer patient prior chemotherapy Fluoropyrimidine Platinum .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>1. histologically cytologically confirm diagnosis gastric adenocarcinoma gastroesophageal junction adenoca ( i.e . adenocarcinoma &gt; 50 % extension stomach ) 2. patient must present stage IV disease amenable surgery , radiation combine modality therapy curative intent . Patients previously undergo local treatment ( surgery and/or radiation ) must subsequently progress recur 3. prior chemotherapy wit fluoropyrimidine platinum 4. measurable evaluable disease accord RECIST 5. age , 18 year old 6 . ECOG performance status 0 2 7. adequate organ function define follow criterion absolute neutrophil count ( ANC ) ≥ 1,500/ul platelet ≥ 100,000/ul AST/ALT ≤ 2.5 x ULN , ≤ 5.0 x ULN liver involvement Total serum bilirubin ≤ 2.0 mg/dL 8. life expectancy ≥ 3 month 9. sign write informed consent 1. one prior chemotherapy metastatic disease 2. severe comorbid illness and/or active infection 3 . NCI CTCAE Grade 3 hemorrhage cause &lt; 4 week enrollment 4. preexist uncontrolled hypertension document 2 baseline blood pressure read take least 1 hour apart 5. pregnant lactate woman 6. active CNS metastasis controllable radiotherapy corticosteroid 7. active uncontrollable bleed gastrointestinal tract 8. known history hypersensitivity study drug 9. prior treatment sunitinib</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>advanced gastric cancer</keyword>
	<keyword>sunitinib</keyword>
	<keyword>docetaxel</keyword>
	<keyword>fluoropyrimidine platinum base chemotherapy</keyword>
</DOC>